The State of A.I. Drug Discovery and Its Future
Implications for small molecule, vaccine and antibody drug development
(This post is sponsored by Syntekabio)
Artificial intelligence (A.I.) and big data in a synergistic integration have led to promising results in new drug development by drastically reducing cost and time. This trend in the biopharmaceutical market has emerged as a new industry standard as startups—each with distinctive core A.I. algorithm—fiercely compet…
Keep reading with a 7-day free trial
Subscribe to Where Tech Meets Bio to keep reading this post and get 7 days of free access to the full post archives.